All

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Posted on by SGW Content
10
Feb

Jacques Ferlay 1, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray
Affiliations Expand
PMID: 25220842 DOI: 10.1002/ijc.29210

Abstract

Estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. We review the sources and methods used in compiling the national cancer incidence and mortality estimates, and briefly describe the key results by cancer site and in 20 large “areas” of the world. Overall, there were 14.1 million new cases and 8.2 million deaths in 2012. The most commonly diagnosed cancers were lung (1.82 million), breast (1.67 million), and colorectal (1.36 million); the most common causes of cancer death were lung cancer (1.6 million deaths), liver cancer (745,000 deaths), and stomach cancer (723,000 deaths).

Keywords: GLOBOCAN; Incidence; cancer; global estimates; mortality.

PubMed Disclaimer

Similar articles

  • Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.PMID: 21351269
  • Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.PMID: 30207593
  • Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

    Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F.Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.PMID: 30350310
  • Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

    Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F.Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9.PMID: 30100160 Review.
  • Progress in cancer mortality, incidence, and survival: a global overview.

    Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, Negri E, Bosetti C, La Vecchia C.Eur J Cancer Prev. 2020 Sep;29(5):367-381. doi: 10.1097/CEJ.0000000000000594.PMID: 32740162 Review.
See all similar articles

Cited by

  • Synthesis and in vitro study of surface-modified and anti-EGFR DNA aptamer -conjugated chitosan nanoparticles as a potential targeted drug delivery system.

    Rahmani Kheyrollahi M, Mohammadnejad J, Eidi A, Jafary H.Heliyon. 2024 Oct 5;10(19):e38904. doi: 10.1016/j.heliyon.2024.e38904. eCollection 2024 Oct 15.PMID: 39435057 Free PMC article.
  • Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase II clinical trial.

    Yang X, Zhai Y, Bi N, Zhang T, Deng L, Wang W, Wang X, Chen D, Zhou Z, Wang L, Liang J.Chin J Cancer Res. 2021 Feb 28;33(1):53-60. doi: 10.21147/j.issn.1000-9604.2021.01.06.PMID: 33707928 Free PMC article.
  • Investigation on the Efficiency of Chinese Herbal Injections for Treating Non-small Cell Lung Cancer With Vinorelbine and Cisplatin Based on Multidimensional Bayesian Network Meta-Analysis.

    Ni M, Wang H, Wang M, Zhou W, Zhang J, Wu J, Zhang D, Jing Z, Liu X, Wu Z, Guo S, Jia S, Zhang X, Sheng X.Front Pharmacol. 2021 Jan 29;11:631170. doi: 10.3389/fphar.2020.631170. eCollection 2020.PMID: 33708126 Free PMC article.
  • Identifying the histologic subtypes of non-small cell lung cancer with computed tomography imaging: a comparative study of capsule net, convolutional neural network, and radiomics.

    Liu H, Jiao Z, Han W, Jing B.Quant Imaging Med Surg. 2021 Jun;11(6):2756-2765. doi: 10.21037/qims-20-734.PMID: 34079739 Free PMC article.
  • Effect of vocal rehabilitation after chemoradiation for non-laryngeal head and neck cancers.

    Sreenivas A, Sreedharan S, Narayan M, Balasubramanium RK, Saxena PP, Banerjee S, Dosamane D, Shenoy V, Kamath MP.Acta Otorhinolaryngol Ital. 2021 Apr;41(2):131-141. doi: 10.14639/0392-100X-N0977.PMID: 34028457 Free PMC article.
SGW Content

Leave a Reply

Your email address will not be published. Required fields are marked *